Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture and Amitriptyline for HIV Neuropathy
NCT00000817Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amitriptyline in peripheral neuropathy (4 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Change in intensity of pain at 14 weeks, Change in quality of life at 14 weeks and 2 more. Started Nov 1994; status: completed.
02
Drugs
amitriptyline
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT00000817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000817.